B
Evidence Grade B
Graded
accuracy verified by the review judge
Safe to Cite
Recent
24%
24% -- top of mind mindshare by drug class for Monoclonal Antibodies (neurology drug class) (2025-07)
Monoclonal Antibodies accounted for 24% of top-of-mind neurologist mindshare when analyzed by drug class.
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
24%
Unit
Percentage
Data Vintage
2025-07
Entity
Sample Size
57
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
95
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
ZoomRx
Primary
Tier A
https://blog.zoomrx.com/promotional-tracking/neurology-brand-mindshare-analysis/ ↗
Source Article
How 100+ Neuro Brands Compete for Neurologist Mindshare | ZoomRx
What drives Neurologists’ mindshare in a space with multiple alternatives?
Executive Summary
The neurology therapeutic landscape is one of the most intensely competitive, creating a significant challenge for pharmaceutical marketers fighting for neurologists’ attention.
Our latest analysis of top-of…
Original Research
ZoomRx
· Original study ↗
Methodology
ZoomRx survey of 57 US neurologists, July 2025; unaided top-of-mind recall
Methodology documented
Segmentation
Industrymarketing
Cite this stat
Plain Text
Monoclonal Antibodies (neurology drug class): 24% top of mind mindshare by drug class. Source: ZoomRx (2025-07). Via Lighthouse Intelligence -- https://lighthousedata.io/data/monoclonal-antibodies-mindshare-24pct
HTML Embed
<blockquote cite="https://lighthousedata.io/data/monoclonal-antibodies-mindshare-24pct" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>24%</strong> -- top of mind mindshare by drug class for Monoclonal Antibodies (neurology drug class)<br><small>Source: ZoomRx (2025-07) · <a href="https://lighthousedata.io/data/monoclonal-antibodies-mindshare-24pct" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.